These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 28453293)

  • 1. Predicting a Drug's Membrane Permeability: A Computational Model Validated With in Vitro Permeability Assay Data.
    Bennion BJ; Be NA; McNerney MW; Lao V; Carlson EM; Valdez CA; Malfatti MA; Enright HA; Nguyen TH; Lightstone FC; Carpenter TS
    J Phys Chem B; 2017 May; 121(20):5228-5237. PubMed ID: 28453293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug permeability across a phospholipid vesicle based barrier: a novel approach for studying passive diffusion.
    Flaten GE; Dhanikula AB; Luthman K; Brandl M
    Eur J Pharm Sci; 2006 Jan; 27(1):80-90. PubMed ID: 16246536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rise of PAMPA.
    Avdeef A
    Expert Opin Drug Metab Toxicol; 2005 Aug; 1(2):325-42. PubMed ID: 16922646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of various PAMPA models to identify the most discriminating method for the prediction of BBB permeability.
    Mensch J; Melis A; Mackie C; Verreck G; Brewster ME; Augustijns P
    Eur J Pharm Biopharm; 2010 Mar; 74(3):495-502. PubMed ID: 20067834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Affordable Membrane Permeability Calculations: Permeation of Short-Chain Alcohols through Pure-Lipid Bilayers and a Mammalian Cell Membrane.
    Tse CH; Comer J; Sang Chu SK; Wang Y; Chipot C
    J Chem Theory Comput; 2019 May; 15(5):2913-2924. PubMed ID: 30998342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physicochemical selectivity of the BBB microenvironment governing passive diffusion--matching with a porcine brain lipid extract artificial membrane permeability model.
    Tsinman O; Tsinman K; Sun N; Avdeef A
    Pharm Res; 2011 Feb; 28(2):337-63. PubMed ID: 20945153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Advances in parallel artificial membrane permeability assay and its applications].
    Wu YF; Liu H; Ni JM
    Yao Xue Xue Bao; 2011 Aug; 46(8):890-5. PubMed ID: 22007511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined application of parallel artificial membrane permeability assay and Caco-2 permeability assays in drug discovery.
    Kerns EH; Di L; Petusky S; Farris M; Ley R; Jupp P
    J Pharm Sci; 2004 Jun; 93(6):1440-53. PubMed ID: 15124203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular simulation of nonfacilitated membrane permeation.
    Awoonor-Williams E; Rowley CN
    Biochim Biophys Acta; 2016 Jul; 1858(7 Pt B):1672-87. PubMed ID: 26706099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of in vitro PAMPA technique and in silico computational methods for blood-brain barrier permeability prediction of novel CNS drug candidates.
    Radan M; Djikic T; Obradovic D; Nikolic K
    Eur J Pharm Sci; 2022 Jan; 168():106056. PubMed ID: 34740787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new PAMPA model using an in-house brain lipid extract for screening the blood-brain barrier permeability of drug candidates.
    Bicker J; Alves G; Fortuna A; Soares-da-Silva P; Falcão A
    Int J Pharm; 2016 Mar; 501(1-2):102-11. PubMed ID: 26836708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH-permeability profiles for drug substances: Experimental detection, comparison with human intestinal absorption and modelling.
    Oja M; Maran U
    Eur J Pharm Sci; 2018 Oct; 123():429-440. PubMed ID: 30100533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of blood-brain barrier permeation of α-adrenergic and imidazoline receptor ligands using PAMPA technique and quantitative-structure permeability relationship analysis.
    Vucicevic J; Nikolic K; Dobričić V; Agbaba D
    Eur J Pharm Sci; 2015 Feb; 68():94-105. PubMed ID: 25542610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the artificial membrane permeability of drugs by digital simulation.
    Nakamura M; Osakai T
    Eur J Pharm Sci; 2016 Aug; 91():154-61. PubMed ID: 27334569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting Passive Permeability of Drug-like Molecules from Chemical Structure: Where Are We?
    Broccatelli F; Salphati L; Plise E; Cheong J; Gobbi A; Lee ML; Aliagas I
    Mol Pharm; 2016 Dec; 13(12):4199-4208. PubMed ID: 27806577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional group dependence of solute partitioning to various locations within a DOPC bilayer: a comparison of molecular dynamics simulations with experiment.
    Tejwani RW; Davis ME; Anderson BD; Stouch TR
    J Pharm Sci; 2011 Jun; 100(6):2136-46. PubMed ID: 21491439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caco-2 permeability of weakly basic drugs predicted with the double-sink PAMPA pKa(flux) method.
    Avdeef A; Artursson P; Neuhoff S; Lazorova L; Gråsjö J; Tavelin S
    Eur J Pharm Sci; 2005 Mar; 24(4):333-49. PubMed ID: 15734300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A fully computational model for predicting percutaneous drug absorption.
    Neumann D; Kohlbacher O; Merkwirth C; Lengauer T
    J Chem Inf Model; 2006; 46(1):424-9. PubMed ID: 16426076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanistic Insights into Passive Membrane Permeability of Drug-like Molecules from a Weighted Ensemble of Trajectories.
    Zhang S; Thompson JP; Xia J; Bogetti AT; York F; Skillman AG; Chong LT; LeBard DN
    J Chem Inf Model; 2022 Apr; 62(8):1891-1904. PubMed ID: 35421313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QSAR study on permeability of hydrophobic compounds with artificial membranes.
    Fujikawa M; Nakao K; Shimizu R; Akamatsu M
    Bioorg Med Chem; 2007 Jun; 15(11):3756-67. PubMed ID: 17418579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.